17 Pages Posted: 10 Nov 2012
Date Written: November 5, 2012
From the earliest days of the Human Genome Project, the holy grail of genomics was the ability to perform whole-genome sequencing quickly, accurately, and relatively inexpensively so that the benefits of genomics would be widely available in clinical settings. Although the mythical $1,000 genome sequence seemed elusive for many years, next-generation sequencing technologies and other recent advances clearly indicate that inexpensive whole-genome sequencing is at hand.
Keywords: genomics, whole genome sequencing, medical screening, genetics, health policy, health privacy, clinical genetics
JEL Classification: K31, K32
Suggested Citation: Suggested Citation
Rothstein, Mark A., The Case Against Precipitous, Population-Wide, Whole-Genome Sequencing (November 5, 2012). Journal of Law, Medicine and Ethics, Vol. 40, No. 3, 2012; University of Louisville School of Law Legal Studies Research Paper Series No. 2013-05. Available at SSRN: https://ssrn.com/abstract=2172821